Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Pandion Therapeutics, Inc. (PAND)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-20Dec-31-19
   10-K10-K
Revenues  8.81.0
            Revenue growth  807.9% 
Cost of goods sold  0.00.0
Gross profit  8.81.0
            Gross margin  100.0%100.0%
Selling, general and administrative   [+]12.85.0
Research and development  33.918.2
EBITDA   [+]-37.4-22.0
            EBITDA margin  -426.2%-2272.7%
Depreciation and amortization  0.50.2
EBIT   [+]-37.9-22.2
            EBIT margin  -432.0%-2297.7%
Interest expense, net   [+]0.3-0.2
Other income (expense), net  0.10.1
Pre-tax income  -38.1-21.9
Income taxes  0.00.0
            Tax rate  0.0%0.0%
Net income  -43.0-25.9
            Net margin  -490.0%-2673.4%
   
Basic EPS   [+]($3.17)($25.00)
Diluted EPS   [+]($3.17)($25.00)
   
Shares outstanding (basic)   [+]13.61.0
Shares outstanding (diluted)   [+]13.61.0
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy